section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Hemat: thrombocytosis

Misc: allergic reactions (rash, urticaria, wheezing)

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

High-Dose Methotrexate—Leucovorin Rescue. Must start within 24 hr of methotrexate.

Advanced Colorectal Cancer

Prevention of Hematologic Toxicity from Pyrimethamine

Inadvertent Overdose of Folic Acid Antagonists

Megaloblastic Anemia

Action

  • The reduced form of folic acid that serves as a cofactor in the synthesis of DNA and RNA.
Therapeutic effects:
  • Reversal of toxic effects of folic acid antagonists.
  • Reversal of folic acid deficiency.

Classifications

Therapeutic Classification: antidotes (for methotrexate), vitamins

Pharmacologic Classification: folic acid analogues

Pharmacokinetics

Absorption: Well absorbed (38%) following PO administration. bioavailability with larger doses. Oral absorption is saturated at doses >25 mg. Well absorbed following IM administration. IV administration results in complete bioavailability.

Distribution: Widely distributed to tissues. Concentrates in the CNS and liver.

Metabolism/Excretion: Extensively converted to tetrahydrofolic derivatives, including 5-methyltetrahydrofolate, a major storage form.

Half-Life: 3.5 hr.

Time/Action Profile

(serum folate concentrations)

ROUTEONSETPEAKDURATION
PO20–30 minunknown3–6 hr
IM10–20 minunknown3–6 hr
IV<5 minunknown3–6 hr



Patient/Family Teaching

Pronunciation

loo-koe-VOR-in